{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:49:32Z","timestamp":1768279772985,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1124\/mol.106.031153","type":"journal-article","created":{"date-parts":[[2006,10,19]],"date-time":"2006-10-19T00:58:34Z","timestamp":1161219514000},"page":"259-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Human Chorionic Gonadotropin Modulates Prostate Cancer Cell Survival after Irradiation or HMG CoA Reductase Inhibitor Treatment"],"prefix":"10.1016","volume":"71","author":[{"given":"Adly","family":"Yacoub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristoffer","family":"Valerie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.106.031153_REF1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0090-4295(01)01253-5","article-title":"Growth factors and their receptors: new targets for prostate cancer therapy","volume":"58","author":"Barton","year":"2001","journal-title":"Urology"},{"key":"10.1124\/mol.106.031153_REF2","doi-asserted-by":"crossref","first-page":"8335","DOI":"10.1074\/jbc.274.12.8335","article-title":"c-Srcmediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function","volume":"274","author":"Biscardi","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.106.031153_REF3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/mc.20138","article-title":"Transactivating agonists of the EGF receptor require Tyr 845 phosphorylation for induction of DNA synthesis","volume":"44","author":"Boerner","year":"2005","journal-title":"Mol Carcinog"},{"key":"10.1124\/mol.106.031153_REF4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/1535-7163.257.4.2","article-title":"Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival","volume":"4","author":"Caron","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/mol.106.031153_REF5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1158\/1535-7163.243.4.2","article-title":"H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent","volume":"4","author":"Caron","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/mol.106.031153_REF6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ygyno.2005.12.047","article-title":"Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1124\/mol.106.031153_REF7","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ejca.2006.02.011","article-title":"Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials","volume":"42","author":"Collette","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1124\/mol.106.031153_REF8","doi-asserted-by":"crossref","first-page":"U89","DOI":"10.1530\/eje.0.151u089","article-title":"Application of gonadotropin releasing hormone in hypogonadotropic hypogonadismdiagnostic and therapeutic aspects","volume":"151","author":"Delemarre-van de Waal","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1124\/mol.106.031153_REF9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ijrobp.2004.04.017","article-title":"Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients","volume":"60","author":"De Meerleer","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1124\/mol.106.031153_REF10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1006\/cyto.1998.0443","article-title":"Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates","volume":"11","author":"De Miguel","year":"1999","journal-title":"Cytokine"},{"key":"10.1124\/mol.106.031153_REF11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.20942","article-title":"Conjugated bile acids promote ERK1\/2 and AKT activation via a pertussis toxinsensitive mechanism in murine and human hepatocytes","volume":"42","author":"Dent","year":"2005","journal-title":"Hepatology"},{"key":"10.1124\/mol.106.031153_REF12","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1091\/mbc.10.8.2493","volume":"10","author":"Dent","year":"1999","journal-title":"Mol Biol Cell"},{"key":"10.1124\/mol.106.031153_REF13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1667\/0033-7587(2003)159[0283:SARIAO]2.0.CO;2","article-title":"Stress and radiation-induced activation of multiple intracellular signaling pathways","volume":"159","author":"Dent","year":"2003","journal-title":"Radiat Res"},{"key":"10.1124\/mol.106.031153_REF14","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/sj.onc.1206701","article-title":"MAPK pathways in radiation responses","volume":"22","author":"Dent","year":"2003","journal-title":"Oncogene"},{"key":"10.1124\/mol.106.031153_REF15","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1210\/me.2004-0174","article-title":"Ectodomain shedding-dependent transactivation of epidermal growth factor receptors in response to insulin-like growth factor type I","volume":"18","author":"El-Shewy","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.106.031153_REF16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.fertnstert.2005.02.033","article-title":"Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility","volume":"84","author":"Filicori","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1124\/mol.106.031153_REF17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/1389557033488196","article-title":"Steroid 5alpha-reductase inhibitors","volume":"3","author":"Flores","year":"2003","journal-title":"Mini Rev Med Chem"},{"key":"10.1124\/mol.106.031153_REF18","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1016\/j.ejca.2004.07.033","article-title":"Dual HER 1-2 targeting of hormone-refractory prostate cancer by ZD1839 and trastuzumab","volume":"40","author":"Formento","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1124\/mol.106.031153_REF19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.20758","article-title":"Cancer risk among statin users: a population-based cohort study","volume":"114","author":"Friis","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1124\/mol.106.031153_REF20","first-page":"1","article-title":"Rho GTPases: promising cellular targets for novel anticancer drugs","volume":"6","author":"Fritz","year":"2006","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1124\/mol.106.031153_REF21","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1200\/JCO.2004.02.027","article-title":"The risk of cancer in users of statins","volume":"22","author":"Graaf","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1124\/mol.106.031153_REF22","first-page":"173","article-title":"Epidermal growth factorinduced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity","volume":"7","author":"Gulli","year":"1996","journal-title":"Cell Growth Differ"},{"key":"10.1124\/mol.106.031153_REF23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1667\/0033-7587(2000)153[0371:IRIMAP]2.0.CO;2","article-title":"Ionizing radiation induced mitogen-activated protein (MAP) kinase activation in DU145 prostate carcinoma cells: MAP kinase inhibition enhances radiation-induced cell killing and G2\/M-phase arrest","volume":"153","author":"Hagan","year":"2000","journal-title":"Radiat Res"},{"key":"10.1124\/mol.106.031153_REF24","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1158\/1078-0432.CCR-04-0420","article-title":"Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinoma","volume":"10","author":"Hagan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.106.031153_REF25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1677\/jme.0.0150283","article-title":"A novel action of epidermal growth factor in rat granulosa cells: its potentiation of gonadotrophin action","volume":"15","author":"Hattori","year":"1995","journal-title":"J Mol Endocrinol"},{"key":"10.1124\/mol.106.031153_REF26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00280-005-0013-8","article-title":"Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies","volume":"57","author":"Holstein","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/mol.106.031153_REF27","first-page":"1285","article-title":"The beta-subunit of human choriogonadotropin interacts with the exodomain of the luteinizing hormone\/choriogonadotropin receptor and changes its interaction with the alpha-subunit","volume":"13","author":"Hong","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.106.031153_REF28","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.1158\/1078-0432.CCR-04-1568","article-title":"3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis","volume":"10","author":"Horiguchi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.106.031153_REF29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.mce.2004.10.013","article-title":"Multiple sites of tumorigenesis in transgenic mice overproducing hCG","volume":"234","author":"Huhtaniemi","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/mol.106.031153_REF30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4161\/cc.5.8.2690","article-title":"Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage","volume":"5","author":"Kolthur-Seetharam","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1124\/mol.106.031153_REF31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/endo.140.1.6414","article-title":"Epidermal growth factor-induced heterologous desensitization of the luteinizing hormone\/choriogonadotropin receptor in a cell-free membrane preparation is associated with the tyrosine phosphorylation of the epidermal growth factor receptor","volume":"140","author":"Lamm","year":"1999","journal-title":"Endocrinology"},{"key":"10.1124\/mol.106.031153_REF32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2741\/1523","article-title":"Selective growth regulatory and proapoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells","volume":"10","author":"Li","year":"2005","journal-title":"Front Biosci"},{"key":"10.1124\/mol.106.031153_REF33","doi-asserted-by":"crossref","first-page":"18980","DOI":"10.1074\/jbc.M211695200","article-title":"Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-\u03baB through the Akt pathway","volume":"278","author":"Mayo","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.106.031153_REF34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(06)70700-8","article-title":"Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy","volume":"7","author":"Messing","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1124\/mol.106.031153_REF35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clon.2004.12.005","article-title":"The emerging role of high-dose-rate brachytherapy for prostate cancer","volume":"17","author":"Morton","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1124\/mol.106.031153_REF36","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.urology.2005.08.053","article-title":"Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer","volume":"66","author":"Moyad","year":"2005","journal-title":"Urology"},{"key":"10.1124\/mol.106.031153_REF37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1014964903540","article-title":"Enhancement of radiosensitivity of the MCF-7 breast cancer cell line with human chorionic gonadotropin","volume":"72","author":"Pond-Tor","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1124\/mol.106.031153_REF38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4161\/cbt.64","article-title":"Pharmocologic inhibitors of the mitogen activated protein kinase cascade have the potential to interact with ionizing radiation exposure to induce cell death in carcinoma cells by multiple mechanisms","volume":"1","author":"Qiao","year":"2002","journal-title":"Cancer Biol Ther"},{"key":"10.1124\/mol.106.031153_REF39","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1053\/j.gastro.2005.09.023","article-title":"Bile salt-induced apoptosis involves NADPH oxidase isoform activation","volume":"129","author":"Reinehr","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.106.031153_REF40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/0470869976.ch12","article-title":"IGF-1 and prostate cancer","volume":"262","author":"Roberts","year":"2004","journal-title":"Novartis Found Symp"},{"key":"10.1124\/mol.106.031153_REF41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00001622-200405000-00009","article-title":"Advances in prostate cancer","volume":"16","author":"Ryan","year":"2004","journal-title":"Curr Opin Oncol"},{"key":"10.1124\/mol.106.031153_REF42","first-page":"259","article-title":"In vitro fertilization and breast cancer risk: a review","volume":"50","author":"Salhab","year":"2005","journal-title":"Int J Fertil Womens Med"},{"key":"10.1124\/mol.106.031153_REF43","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1200\/JCO.2004.02.141","article-title":"The biology and clinical relevance of the PTEN tumor suppressor pathway","volume":"22","author":"Sansal","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1124\/mol.106.031153_REF44","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1356-9597.2003.00691.x","article-title":"Src-dependent phosphorylation of the EGF receptor Tyr-845 mediates Stat-p21waf1 pathway in A431 cells","volume":"8","author":"Sato","year":"2003","journal-title":"Genes Cells"},{"key":"10.1124\/mol.106.031153_REF45","first-page":"545","article-title":"Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms","volume":"1","author":"Scher","year":"1995","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.106.031153_REF46","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1963","article-title":"Poly(ADP-ribose): novel functions for an old molecule","volume":"7","author":"Schreiber","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/mol.106.031153_REF47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/jcp.49.4.329","article-title":"beta hCG as a prognostic marker in adenocarcinoma of the prostate","volume":"49","author":"Sheaff","year":"1996","journal-title":"J Clin Pathol"},{"key":"10.1124\/mol.106.031153_REF48","doi-asserted-by":"crossref","first-page":"C545","DOI":"10.1152\/ajpcell.00260.2001","article-title":"Autocrine loops with positive feedback enable context-dependent cell signaling","volume":"282","author":"Shvartsman","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.106.031153_REF49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.metabol.2004.07.006","article-title":"Human chorionic gonadotropin therapy in adolescent boys with constitutional delayed puberty vs those with beta-thalassemia major","volume":"54","author":"Soliman","year":"2005","journal-title":"Metabolism"},{"key":"10.1124\/mol.106.031153_REF50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0047-6374(01)00354-2","article-title":"Effect of growth factors on nuclear and mitochondrial ADP-ribosylation processes during astroglial cell development and aging in culture","volume":"123","author":"Spina Purrello","year":"2002","journal-title":"Mech Ageing Dev"},{"key":"10.1124\/mol.106.031153_REF51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0889-8529(18)30281-0","article-title":"Puberty and its disorders in boys","volume":"20","author":"Styne","year":"1991","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1124\/mol.106.031153_REF52","first-page":"483","article-title":"Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer","volume":"2","author":"Thibault","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.106.031153_REF53","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood-2003-03-0970","article-title":"Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels","volume":"102","author":"van de Donk","year":"2003","journal-title":"Blood"},{"key":"10.1124\/mol.106.031153_REF54","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1158\/0008-5472.CAN-04-0866","article-title":"Blocking the Raf\/MEK\/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatininduced apoptosis","volume":"64","author":"Wu","year":"2004","journal-title":"Cancer Res"},{"key":"10.1124\/mol.106.031153_REF55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10549-005-1040-1","article-title":"Gene 33 inhibits apoptosis of breast cancer cells and increases poly(ADP-ribose) polymerase expression","volume":"91","author":"Xu","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1124\/mol.106.031153_REF56","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1124\/mol.106.025007","article-title":"OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cells","volume":"70","author":"Yacoub","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.106.031153_REF57","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.cellbi.2006.04.004","article-title":"Epidermal growth factor (EGF) induces apoptosis in a transfected cell line expressing EGF receptor on its membrane","volume":"30","author":"Zhao","year":"2006","journal-title":"Cell Biol Int"}],"updated-by":[{"DOI":"10.1124\/mol.115.031153err","type":"correction","label":"Correction","source":"retraction-watch","updated":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T00:00:00Z","timestamp":1468368000000},"record-id":"9547"},{"DOI":"10.1124\/mol.115.031153err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000}}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24043049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24043049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.106.031153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:41:44Z","timestamp":1739965304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24043049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0026895X24043049"],"URL":"https:\/\/doi.org\/10.1124\/mol.106.031153","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Chorionic Gonadotropin Modulates Prostate Cancer Cell Survival after Irradiation or HMG CoA Reductase Inhibitor Treatment","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.106.031153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}